Evidence map›Paper›PMID 33339139›Full record

ArticleInternational journal of molecular sciences2020

Design of Polymeric and Biocompatible Delivery Systems by Dissolving Mesoporous Silica Templates.

Ana Rodríguez-Ramos, Laura Marín-Caba, Nerea Iturrioz-Rodríguez, Esperanza Padín-González, Lorena García-Hevia, Teresa Mêna Oliveira, Miguel A Corea-Duarte, Mónica L Fanarraga

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. The Physical Chemistry and Chemical Physics (PCCP) Section of theInternational journal of molecular sciences · 2021
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ana Rodríguez-RamosGrupo de Nanomedicina, Instituto Valdecilla-IDIVAL, Herrera Oria s/n, 39011 Santander, Spain.ORCID 0000-0003-3422-2886
Laura Marín-CabaCINBIO, Universidade de Vigo, 36310 Vigo, Spain.
Nerea Iturrioz-RodríguezGrupo de Nanomedicina, Instituto Valdecilla-IDIVAL, Herrera Oria s/n, 39011 Santander, Spain.ORCID 0000-0003-3698-9570
Esperanza Padín-GonzálezGrupo de Nanomedicina, Instituto Valdecilla-IDIVAL, Herrera Oria s/n, 39011 Santander, Spain.
Lorena García-HeviaGrupo de Nanomedicina, Instituto Valdecilla-IDIVAL, Herrera Oria s/n, 39011 Santander, Spain.ORCID 0000-0001-8275-7733
Teresa Mêna OliveiraCINBIO, Universidade de Vigo, 36310 Vigo, Spain.
Miguel A Corea-DuarteCINBIO, Universidade de Vigo, 36310 Vigo, Spain.ORCID 0000-0003-1950-1414
Mónica L FanarragaGrupo de Nanomedicina, Instituto Valdecilla-IDIVAL, Herrera Oria s/n, 39011 Santander, Spain.ORCID 0000-0003-4754-311X
Instituto de Investigación Marqués de Valdecilla · ESUniversidade de Vigo · ESGalicia Sur Biomedical Foundation · ESUniversidad de Cantabria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are many nanoencapsulation systems available today. Among all these, mesoporous silica particles (MSPs) have received great attention in the last few years. Their large surface-to-volume ratio, biocompatibility, and versatility allow the encapsulation of a wide variety of drugs inside their pores. However, their chemical instability in biological fluids is a handicap to program the precise release of the therapeutic compounds. Taking advantage of the dissolving capacity of silica, in this study, we generate hollow capsules using MSPs as transitory sacrificial templates. We show how, upon MSP coating with different polyelectrolytes or proteins, fully customized hollow shells can be produced. These capsules are biocompatible, flexible, and biodegradable, and can be decorated with nanoparticles or carbon nanotubes to endow the systems with supplementary intrinsic properties. We also fill the capsules with a fluorescent dye to demonstrate intracellular compound release. Finally, we document how fluorescent polymeric capsules are engulfed by cells, releasing their encapsulated agent during the first 96 h. In summary, here, we describe how to assemble a highly versatile encapsulation structure based on silica mesoporous cores that are completely removed from the final polymeric capsule system. These drug encapsulation systems are highly customizable and have great versatility as they can be made using silica cores of different sizes and multiple coatings. This provides capsules with unique programmable attributes that are fully customizable according to the specific needs of each disease or target tissue for the development of nanocarriers in personalized medicine.

Indexed as

Drug LiberationFluorescent DyesHeLa CellsHumansNanocapsulesPolyelectrolytesSilicon DioxideFluorescent DyesNanocapsulesPolyelectrolytesSilicon Dioxidedeliverydissolutionnanocarrier systempolymersilica particle

Identifiers

PMID33339139
PMCPMC7765674
OpenAlexW3113101209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.